These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 10341398)
1. First-trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union? Thilaganathan B Ultrasound Obstet Gynecol; 1999 Apr; 13(4):229-30. PubMed ID: 10341398 [No Abstract] [Full Text] [Related]
2. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening. Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311 [TBL] [Abstract][Full Text] [Related]
4. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399 [TBL] [Abstract][Full Text] [Related]
5. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases. Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230 [TBL] [Abstract][Full Text] [Related]
6. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. Crossley JA; Aitken DA; Cameron AD; McBride E; Connor JM BJOG; 2002 Jun; 109(6):667-76. PubMed ID: 12118646 [TBL] [Abstract][Full Text] [Related]
7. Screening for Down's syndrome--too many choices? Mennuti MT; Driscoll DA N Engl J Med; 2003 Oct; 349(15):1471-3. PubMed ID: 14534341 [No Abstract] [Full Text] [Related]
8. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy]. Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832 [TBL] [Abstract][Full Text] [Related]
9. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Spencer K Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030 [TBL] [Abstract][Full Text] [Related]
10. [Prenatal Down's syndrome screening at 10-14 weeks gestation using the combined nuchal translucency and maternal serum biochemistry: preliminary results of the first 358 cases]. Maymon R; Bergman M; Segal S; Dreazen E; Weinraub Z; Herman A Harefuah; 2001 Jul; 140(7):594-9, 679. PubMed ID: 11481959 [TBL] [Abstract][Full Text] [Related]
11. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system. Kublickas M; Crossley J; Aitken D Acta Obstet Gynecol Scand; 2009; 88(6):635-8, 7p following 638. PubMed ID: 19330568 [TBL] [Abstract][Full Text] [Related]
12. First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free beta-hCG and PAPP-A. Spencer K; Nicolaides KH Prenat Diagn; 2000 Aug; 20(8):683-4. PubMed ID: 10951484 [No Abstract] [Full Text] [Related]
15. Nuchal translucency measurement and second-trimester biochemical screening for Down's syndrome. Frohlich EP Ultrasound Obstet Gynecol; 1997 Sep; 10(3):221-2. PubMed ID: 9339533 [No Abstract] [Full Text] [Related]
16. Screening of maternal serum for fetal Down's syndrome in the first trimester. Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983 [TBL] [Abstract][Full Text] [Related]
17. First trimester screening for Down's syndrome using maternal serum PAPP-A and free beta-hCG in combination with fetal nuchal translucency thickness. Biagiotti R; Brizzi L; Periti E; d'Agata A; Vanzi E; Cariati E Br J Obstet Gynaecol; 1998 Aug; 105(8):917-20. PubMed ID: 9746387 [TBL] [Abstract][Full Text] [Related]
18. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers. Muller F; Benattar C; Audibert F; Roussel N; Dreux S; Cuckle H Prenat Diagn; 2003 Oct; 23(10):833-6. PubMed ID: 14558029 [TBL] [Abstract][Full Text] [Related]
19. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach]. Senat MV; Rozenberg P; Bernard JP; Ville Y J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502 [No Abstract] [Full Text] [Related]
20. The use of nuchal translucency in contemporary obstetric practice. Said S; Malone FD Clin Obstet Gynecol; 2008 Mar; 51(1):37-47. PubMed ID: 18303498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]